Position in JNJ
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$137,630,719
+$18,112,542 QoQ
Shares Held
563,045
-2.5% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.73%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026MetLife Investment Management, LLC holds $714,031,909 across 12 Drug Manufacturers - General names. JNJ ranks #2 (19.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
221,464 | $203,695,943 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
563,045 | $137,630,719 | |
| 3 | ABBV |
AbbVie Inc.
|
493,002 | $107,223,004 | |
| 4 | MRK |
Merck & Co., Inc.
|
580,004 | $69,768,681 | |
| 5 | AMGN |
Amgen Inc
|
143,722 | $50,568,585 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
305,106 | $42,522,623 | |
| 7 | PFE |
Pfizer Inc
|
1,328,456 | $37,303,044 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
493,565 | $29,934,717 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $137,630,719 | 563,045 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $119,518,177 | 577,522 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $110,792,714 | 597,523 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $93,648,886 | 613,086 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $103,721,974 | 625,434 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $92,173,412 | 637,349 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $101,457,663 | 626,050 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $93,842,028 | 642,050 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $89,175,499 | 563,724 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $91,607,006 | 584,452 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $92,775,446 | 595,669 | Shares | Defined | 2024-05-09 | |
| 2023-06-30 | $109,188,578 | 659,670 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $104,642,050 | 675,110 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $120,686,396 | 683,195 | Shares | Defined | 2023-03-23 | |
| 2022-09-30 | $114,019,725 | 697,966 | Shares | Defined | 2023-03-23 | |
| 2022-06-30 | $125,841,809 | 708,928 | Shares | Defined | 2023-03-23 | |
| 2022-03-31 | $126,965,090 | 716,386 | Shares | Defined | 2023-03-23 | |
| 2021-12-31 | $99,503,036 | 581,651 | Shares | Defined | 2023-03-23 | |
| 2021-09-30 | $104,498,090 | 647,047 | Shares | Defined | 2023-03-23 | |
| 2021-06-30 | $100,580,524 | 610,541 | Shares | Defined | 2023-03-23 | |
| 2021-03-31 | $110,568,270 | 672,761 | Shares | Defined | 2023-03-23 | |
| 2020-12-31 | $100,617,440 | 639,328 | Shares | Defined | 2023-03-23 | |
| 2020-09-30 | $99,382,908 | 667,537 | Shares | Defined | 2023-03-23 | |
| 2020-06-30 | $96,900,398 | 689,045 | Shares | Defined | 2023-03-23 | |
| 2020-03-31 | $88,958,460 | 678,399 | Shares | Defined | 2023-03-23 | |
| No filing history on record for this holder in this stock. | ||||||